ASX 200 healthcare share sinks on $2 billion asset sale

Investors are pressuring the healthcare share amid news of a major hospital sale.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) healthcare share Ramsay Health Care Ltd (ASX: RHC) is slipping today.

The healthcare stock closed on Friday trading for $53.93 a share. In early trade on Monday, shares are swapping hands for $53.35, down 1.08%.

For some context, the ASX 200 is down 0.19% at this same time.

This comes following news of a multi-billion-dollar hospital asset sale.

Shot of a mature scientists working on a laptop in a lab.

Image source: Getty Images

What did the ASX 200 healthcare share announce?

ASX 200 investors are pressuring the healthcare share after the company reported it has reached an agreement – together with its partner Sime Darby Holdings Berhad – to sell its 50:50 joint venture in Asia, Ramsay Sime Darby Health Care.

Columbia Asia Healthcare will pay MYR6.06 billion (approximately AU$2 billion) for hospital assets, representing 100% of the joint venture's enterprise value.

Ramsay said it expects to achieve a net profit after tax (NPAT) for its share of the joint venture of around $630 million. This will be reflected in the company's FY 2024 full-year results through the "discontinued operations line".

Management expects pre-tax (post-transaction cost) proceeds of around $935 million. The ASX 200 healthcare share will use the funds to pay down debt. This is expected to result in annualised interest cost savings of $55 million.

FY 2024 net interest costs (including AASB16 lease costs) are now expected to be at the lower end of Ramsay's previously guided range of $570 million to $600 million.

Commenting on the asset sale, Sime Darby CEO Jeffri Salim Davidson said, "While the hospital business is a great asset … the offer from Columbia Asia was one we could not refuse."

Subject to the receipt of regulatory approval from Australia's Foreign Investment Review Board, the sale is expected to be completed by the end of 3Q FY 2024.

Ramsay Health Care share price snapshot

Up 7% over the past month, the ASX 200 healthcare share remains down almost 13% over the past full year.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A group of people push and shove through the doors of a store, trying to beat the crowd.
Share Market News

Investors are buying CSL shares again. Should you?

Some experts believe that 2026 could mark the low point for the biotech company.

Read more »

A group of young people celebrate and party outside.
Healthcare Shares

If I'd invested $5,000 in 4DMedical shares 12 months ago, guess how much I'd have now!

Can the company's share price keep accelerating even higher? Here's what analysts tip for the next 12 months.

Read more »

Stressed, unhappy, and tired scientist with a headache working on a computer in a lab.
Healthcare Shares

3 reasons I'd buy CSL shares in FY27

It still needs to rebuild trust, but lower expectations and several recovery levers make the shares worth considering.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Healthcare Shares

CSL shares jump 15%: Is it time to start buying the beaten-down biotech stock?

CSL shares have climbed 7% higher over the past week alone.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

Why is this ASX biotech rocketing more than 20%?

A deal potentially worth hundreds of millions has been struck.

Read more »

Young girl shows hearing aid while smiling.
Healthcare Shares

3 reasons to buy Cochlear shares in June

After a brutal sell-off, the stock may be gearing up for a recovery.

Read more »

patient with doctor, medical company, medical insurance
Cheap Shares

CSL shares trade at just 12 times forecast earnings. Here's why they could be the buy of the decade

The ASX 200 healthcare giant is down more than 60% since August 2025.

Read more »

Falling pills in a blue background.
Healthcare Shares

Sigma Healthcare shares are surging. What does Macquarie say they're worth?

A possible deal has fallen over, which investors appear to like.

Read more »